GM-CSF as a therapeutic target in inflammatory diseases
- PMID: 23933508
- DOI: 10.1016/j.molimm.2013.05.002
GM-CSF as a therapeutic target in inflammatory diseases
Abstract
GM-CSF is a well-known haemopoietic growth factor that is used in the clinic to correct neutropaenia, usually as a result of chemotherapy. GM-CSF also has many pro-inflammatory functions and recent data implicates GM-CSF as a key factor in Th17 driven autoimmune inflammatory conditions. In this review we summarize the findings that have led to the development of GM-CSF antagonists for the treatment of autoimmune diseases like rheumatoid arthritis (RA) and discuss some results of recent clinical trials of these agents.
Keywords: Autoimmune disease; Autoimmunity; Cytokines; GM-CSF; GM-CSF receptor; Inflammatory disease; Rheumatoid arthritis; T cells; Th17 pathway.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
